Intravenous cyclophosphamide in refractory polyneuropathy associated with IgM monoclonal gammopathy: an uncontrolled open trial.
Hamidou
Mohamed A
MA
Department of Internal Medicine, University Hospital, Hôtel-Dieu, Place Alexis Ricordeau, Nantes 44-035, France. mohamed.hamidou@chu-nantes.fr
Belizna
Cristina
C
Wiertlewsky
Sandrine
S
Audrain
Marie
M
Biron
Charlotte
C
Grolleau
Jean-Yves
JY
Mussini
Jean-Marie
JM
D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000150:complications*; D011115:Polyneuropathies / Q000188:drug therapy*; D011446:Prospective Studies; D020551:Pulse Therapy, Drug; D016896:Treatment Outcome
D007075:Immunoglobulin M; D003520:Cyclophosphamide